Ernexa Therapeutics Inc.

ERNA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$1,729$7,575$11,446$16,985
Short-Term Investments$0$0$0$0
Receivables$437$425$951$684
Inventory$0$0$0$0
Other Curr. Assets$186$1,599$1,284$1,097
Total Curr. Assets$2,352$9,599$13,681$18,766
Property Plant & Equip (Net)$755$33,274$1,266$3,237
Goodwill$2,044$2,044$2,044$2,044
Intangibles$0$0$0$5,990
Long-Term Investments$0$0$59$1,000
Tax Assets$0$0$0$0
Other NC Assets$118$4,215$5,229$488
Total NC Assets$2,917$39,533$8,598$12,759
Other Assets$0$0$0$0
Total Assets$5,269$49,132$22,279$31,525
Liabilities
Payables$1,721$1,067$1,620$1,755
Short-Term Debt$207$2,216$2,045$426
Tax Payable$3$2$0$0
Deferred Revenue$0$190$0$0
Other Curr. Liab.$1,007$3,098$3,989$1,496
Total Curr. Liab.$2,938$6,573$7,654$3,677
LT Debt$477$39,627$2,093$2,297
Deferred Rev, NC$0$392$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$153$307$425$47
Total NC Liab.$630$40,326$2,518$2,344
Other Liabilities$0$0$0$0
Cap. Leases$477$35,070$1,182$2,723
Total Liabilities$3,568$46,899$10,172$6,021
Equity
Pref Stock$1$1$1$2
Common Stock$257$27$26$13
Retained Earnings-$231,536-$186,981-$165,297-$140,702
AOCI$0$0$0$0
Other Equity$232,979$189,186$177,377$166,191
Total Equity$1,701$2,233$12,107$25,504
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$5,269$49,132$22,279$31,525
Net Debt-$1,045$34,268-$7,308-$14,262
Ernexa Therapeutics Inc. (ERNA) Financial Statements & Key Stats | AlphaPilot